Millipore Sigma Vibrant Logo

400091 HIF-Hydroxylase Inhibitor, DMOG - CAS 89464-63-1 - Calbiochem

View This Product on Sigma-Aldrich
400091
価格&在庫状況を照会

概要

Replacement Information

主要スペック表

CAS #Empirical Formula
89464-63-1C₆H₉NO₅

価格&在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
400091-50MGCN
在庫状況検索中…
現在国内在庫なし
現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      ガラスビン 50 mg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示 
      値引
      ()
       
      弊社照会
      Description
      OverviewA cell-permeable 2-OG (2-oxoglutarate) analog that is expected to act as a competitive inhibitor against all 2-OG-dependent dioxygenases. Effectively upregulates normoxia HIF-α transcription activity (effective conc. = 1 mM in cultures) by inhibiting HIF-PH- (HIF-α-prolyl hydroxylase) catalyzed ODD (oxygen-dependent degradation domain) Prolyl hydroxylation (Pro564 and Pro530 in HIF-1α and HIF-2α, respectively) and aspartyl/asparanginyl β-hydroxylase-catalyzed CAD Asp hydroxylation (Asn803 and Asn851 in HIF-1α and HIF-2α, respectively), resulting in a blockage of pVHL (von Hippel-Lindau) ubiquitin ligase complex-mediated HIF-α degradation and a simultaneous promotion of HIF CAD (COOH-terminal activation domain) p300/CBP association. DMOG is also demonstrated to augment artery ligation-induced up-regulation of HIF-1α and FLK (by 100% and 40%, respectively, in 11 days; 8 mg/0.5 ml/animal/i.p.; q.o.d.) in muscle tissues in a murine ischaemic model in vivo.
      Catalogue Number400091
      Brand Family Calbiochem®
      SynonymsN-(Methoxyoxoacetyl)-glycine methyl ester, Dimethyloxalylglycine, HIF Prolyl Hydroxylase Inhibitor I, HIF Aspartyl β-Hydroxylase Inhibitor, HIF Asparanginyl β-Hydroxylase Inhibitor
      References
      ReferencesPollard, P.J., et al. 2008. Biochem. J. 416, 387.
      Chen, H., et al. 2006. Cancer Res. 66, 9009.
      Milkiewicz, M., et al. 2004. J. Physiol. 560, 21.
      Lando, D., et al. 2002. Science 295, 858.
      Jaakkola, P., et al. 2001. Science 292, 468.
      Product Information
      CAS number89464-63-1
      FormPink-white to peach-white
      Hill FormulaC₆H₉NO₅
      Chemical formulaC₆H₉NO₅
      Hygroscopic Hygroscopic
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      ApplicationHIF-Hydroxylase Inhibitor, DMOG, CAS 89464-63-1, is a cell-permeable 2-oxoglutarate (2-OG) analog that acts as a competitive inhibitor against all 2-OG-dependent dioxygenases.
      Biological Information
      Purity≥98% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      400091-50MGCN 04055977212389

      Documentation

      HIF-Hydroxylase Inhibitor, DMOG - CAS 89464-63-1 - Calbiochem (M)SDS

      タイトル

      英語版製品安全データシート((M)SDS) 

      HIF-Hydroxylase Inhibitor, DMOG - CAS 89464-63-1 - Calbiochem 試験成績書(CoA)

      タイトルロット番号
      400091

      参考資料

      参考資料の概要
      Pollard, P.J., et al. 2008. Biochem. J. 416, 387.
      Chen, H., et al. 2006. Cancer Res. 66, 9009.
      Milkiewicz, M., et al. 2004. J. Physiol. 560, 21.
      Lando, D., et al. 2002. Science 295, 858.
      Jaakkola, P., et al. 2001. Science 292, 468.
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision06-June-2015 JSW
      SynonymsN-(Methoxyoxoacetyl)-glycine methyl ester, Dimethyloxalylglycine, HIF Prolyl Hydroxylase Inhibitor I, HIF Aspartyl β-Hydroxylase Inhibitor, HIF Asparanginyl β-Hydroxylase Inhibitor
      DescriptionA cell-permeable 2-OG (2-oxoglutarate) analog that is expected to act as a competitive inhibitor against all 2-OG-dependent dioxygenases. Effectively upregulates normoxia HIF-α transcription activity (effective conc. = 1 mM in cultures) by inhibiting HIF-PH- (HIF-α-prolyl hydroxylase) catalyzed ODD (oxygen-dependent degradation domain) Prolyl hydroxylation (Pro564 and Pro530 in HIF-1α and HIF-2α, respectively) and aspartyl/asparanginyl β-hydroxylase-catalyzed CAD Asp hydroxylation (Asn803 and Asn851 in HIF-1α and HIF-2α, respectively), resulting in a blockage of pVHL (von Hippel-Lindau) ubiquitin ligase complex-mediated HIF-α degradation and a simultaneous promotion of HIF CAD (COOH-terminal activation domain) p300/CBP association. DMOG is also demonstrated to augment artery ligation-induced up-regulation of HIF-1α and FLK (by 100% and 40%, respectively, in 11 days; 8 mg/0.5 ml/animal/i.p.; q.o.d.) in muscle tissues in a murine ischaemic model in vivo.
      FormPink-white to peach-white
      CAS number89464-63-1
      Chemical formulaC₆H₉NO₅
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityDMSO (50 mg/ml)
      Storage +2°C to +8°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesPollard, P.J., et al. 2008. Biochem. J. 416, 387.
      Chen, H., et al. 2006. Cancer Res. 66, 9009.
      Milkiewicz, M., et al. 2004. J. Physiol. 560, 21.
      Lando, D., et al. 2002. Science 295, 858.
      Jaakkola, P., et al. 2001. Science 292, 468.